Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Appel, J M
2008.
When the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology.
Journal of Medical Ethics,
Vol. 34,
Issue. 8,
p.
616.
Levy, Neil
and
Clarke, Steve
2008.
Neuroethics and psychiatry.
Current Opinion in Psychiatry,
Vol. 21,
Issue. 6,
p.
568.
Fuller, Steve
2009.
Knowledge politics and new converging technologies: a social epistemological perspective.
Innovation: The European Journal of Social Science Research,
Vol. 22,
Issue. 1,
p.
7.
Ravelingien, A.
Braeckman, J.
Crevits, L.
De Ridder, D.
and
Mortier, E.
2009.
‘Cosmetic Neurology’ and the Moral Complicity Argument.
Neuroethics,
Vol. 2,
Issue. 3,
p.
151.
Grunwell, Jocelyn
Illes, Judy
and
Karkazis, Katrina
2009.
Advancing Neuroregenerative Medicine: a Call for Expanded Collaboration Between Scientists and Ethicists.
Neuroethics,
Vol. 2,
Issue. 1,
p.
13.
Baertschi, Bernard
2009.
La neuroéthique.
p.
161.
Soyka, Michael
and
Gorelick, David A.
2009.
Why should addiction medicine be an attractive field for young physicians?.
Addiction,
Vol. 104,
Issue. 2,
p.
169.
Larriviere, D
and
Williams, M A
2010.
Neuroenhancement: Wisdom of the Masses or ”False Phronesis”?.
Clinical Pharmacology & Therapeutics,
Vol. 88,
Issue. 4,
p.
459.
Racine, Eric
and
Forlini, Cynthia
2010.
Cognitive Enhancement, Lifestyle Choice or Misuse of Prescription Drugs?.
Neuroethics,
Vol. 3,
Issue. 1,
p.
1.
Hamilton, Roy
Messing, Samuel
and
Chatterjee, Anjan
2011.
Rethinking the thinking cap.
Neurology,
Vol. 76,
Issue. 2,
p.
187.
Fuller, Steve
2012.
The emerging political economy of Humanity 2.0.
Innovation: The European Journal of Social Science Research,
Vol. 25,
Issue. 1,
p.
79.
Chandler, Jennifer A.
2013.
Autonomy and the Unintended Legal Consequences of Emerging Neurotherapies.
Neuroethics,
Vol. 6,
Issue. 2,
p.
249.
Levinson, Jack
and
McKinney, Kelly A.
2013.
Consuming an edge: ADHD, stimulant use, and psy culture at the corporate university.
Transcultural Psychiatry,
Vol. 50,
Issue. 3,
p.
371.
Chatterjee, Anjan
2013.
Ethical and Legal Issues in Neurology.
Vol. 118,
Issue. ,
p.
323.
Sattler, Sebastian
Sauer, Carsten
Mehlkop, Guido
Graeff, Peter
and
Taffe, Michael
2013.
The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers.
PLoS ONE,
Vol. 8,
Issue. 7,
p.
e68821.
Mereu, Maddalena
Bonci, Antonello
Newman, Amy Hauck
and
Tanda, Gianluigi
2013.
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.
Psychopharmacology,
Vol. 229,
Issue. 3,
p.
415.
Graf, William D.
Nagel, Saskia K.
Epstein, Leon G.
Miller, Geoffrey
Nass, Ruth
and
Larriviere, Dan
2013.
Pediatric neuroenhancement.
Neurology,
Vol. 80,
Issue. 13,
p.
1251.
Sattler, Sebastian
Mehlkop, Guido
Graeff, Peter
and
Sauer, Carsten
2014.
Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics.
Substance Abuse Treatment, Prevention, and Policy,
Vol. 9,
Issue. 1,
Wade, Lucie
Forlini, Cynthia
and
Racine, Eric
2014.
Generating genius: how an Alzheimer’s drug became considered a ‘cognitive enhancer’ for healthy individuals.
BMC Medical Ethics,
Vol. 15,
Issue. 1,
Dubljević, Veljko
Sattler, Sebastian
and
Racine, Éric
2014.
Cognitive Enhancement and Academic Misconduct: A Study Exploring Their Frequency and Relationship.
Ethics & Behavior,
Vol. 24,
Issue. 5,
p.
408.